Table 2

cDNA array overexpression ratio and quantitative real time RT-PCR* overexpression fold in malignant gastrointestinal stromal tumours (GISTs) compared with benign GISTs

GeneVIL2COL8CCNB1HMG2TSG101CENP-FFAKDYRK2
GeneBank accession NoX51521X57527M25753X62534X13293U19769L13616Y13493
Chromosomal locus6q25.33q12−q13.15q124q3111p151q32–q418q24−qter12q13.13
Gene expression alterations in six malignant GISTs (GIST 4–9) compared with expression of three benign GISTs (GIST 1–3) using cDNA arrays and quantitative real time reverse transcription-polymerase chain reaction (RT-PCR).
*Standard deviation for microarray overexpression fold is shown in parentheses and quantitative real time RT-PCR overexpression is shown in square parentheses.
VIL2, villin 2; COL8A1, collagen 8 alpha 1 subunit; CCNB1, G2/mitotic specific cyclin B1; HMG2, high mobility group protein; TSG101, TSG101 tumour susceptibility protein; CENP-F, CENP-F kinetochore protein; FAK, protein tyrosine kinase 2; DYRK2, protein kinase DYRK2.
Sample
    GIST49.1 (2.3)) [8]3.4 (0.4)) [1.2]3.1 (0.4) [1.9]3.9 (1.1) [13.8]3.6 (1.2) [1.1]5.1 (1.7) [5.5]5.8 (0.7) [2.9]5.7 (0.5) [1.9]
    GIST58.6 (3.1) [4.6]9.7 (0.6) [11.4]2.7 (0.9) [1]2.9 (0.9) [18.3]4.1 (0.5) [2.4]1 (0.3) [1.4]2.7 (0.2) [1]2.7 (0.4) [1.2]
    GIST66.8 (1.4) [3.7]4.7 (0.8) [16]6.2 (1.5) [24.2]4.3 (1.7) [18.6]3.2 (1.4) [2.4]8.7 (2.7) [1.4]4.9 (1.4) [2.6]4.7 (0.8) [6.3]
    GIST73.2 (1.1) [13.7]5.4 (1.1) [59.6]3.1 (1.5) [8.6]3.2 (0.4) [7]2.8 (0.6) [2.6]2.5 (1.9) [8.2]2.5 (0.6) [5.3]2.5 (0.5) [5.7]
    GIST89.8 (1.3) [13.7]4.3 (0.9) [9.2]6.1 (1.8) [12.1]3.1 (0.4) [1.9]2 (0.4) [1.5]3.8 (1.1) [11.1]5.2 (1.2) [1.9]3.6 (0.7) [1.2]
    GIST92.6 (0.7) [1.5]0.8 (0.2) [0]3.1 (0.8) [13.0]4.7 (1.3) [6.4]3.8 (0.6) [1.8]4.8 (1.2) [10.9]3.5 (0.7) [2.3]1.3 (0.8) [1.7]